Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX. / Christensen, Thomas; Jørgensen, M B; Diemer, Nils Henrik.

In: Acta Neurologica Scandinavica, Vol. 87, No. 6, 1993, p. 510-515.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Christensen, T, Jørgensen, MB & Diemer, NH 1993, 'Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX', Acta Neurologica Scandinavica, vol. 87, no. 6, pp. 510-515.

APA

Christensen, T., Jørgensen, M. B., & Diemer, N. H. (1993). Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX. Acta Neurologica Scandinavica, 87(6), 510-515.

Vancouver

Christensen T, Jørgensen MB, Diemer NH. Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX. Acta Neurologica Scandinavica. 1993;87(6):510-515.

Author

Christensen, Thomas ; Jørgensen, M B ; Diemer, Nils Henrik. / Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX. In: Acta Neurologica Scandinavica. 1993 ; Vol. 87, No. 6. pp. 510-515.

Bibtex

@article{0c6094b074cf11dbbee902004c4f4f50,
title = "Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX",
abstract = "In the present immunocytochemical study, we investigated the mechanism of Fos protein induction and the regional distribution of the Fos protein in brains of spontaneously hypertensive rats subjected to 2 h of permanent middle cerebral artery occlusion (MCAO). Rats were administered either saline or a glutamate receptor antagonist; the non-competitive NMDA receptor antagonist MK-801 or the AMPA receptor antagonist NBQX which are known to be able to reduce infarct size in MCA occluded rats. The saline treated rats showed presence of Fos protein in nerve cell nuclei throughout the cortical and striatal infarct borderzone, but no staining in the infarct core or contralateral hemisphere. MK-801 almost totally abolished this expression of Fos protein whereas NBQX had no significant effect on Fos protein expression. It is suggested that the Fos protein induction is due to repeated spreading depressions mediated by NMDA receptors in the infarct borderzone, and that Fos protein due to its persistence in the tissue can be used as a histochemical marker of borderzone tissue at risk for eventually becoming recruited in the infarct.",
keywords = "Animals, Cerebral Cortex, Cerebral Infarction, Corpus Striatum, Cortical Spreading Depression, Dizocilpine Maleate, Energy Metabolism, Gene Expression Regulation, Male, Neurons, Proto-Oncogene Proteins c-fos, Quinoxalines, Rats, Rats, Inbred SHR, Receptors, N-Methyl-D-Aspartate",
author = "Thomas Christensen and J{\o}rgensen, {M B} and Diemer, {Nils Henrik}",
year = "1993",
language = "English",
volume = "87",
pages = "510--515",
journal = "Acta Neurologica Scandinavica",
issn = "0001-6314",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX

AU - Christensen, Thomas

AU - Jørgensen, M B

AU - Diemer, Nils Henrik

PY - 1993

Y1 - 1993

N2 - In the present immunocytochemical study, we investigated the mechanism of Fos protein induction and the regional distribution of the Fos protein in brains of spontaneously hypertensive rats subjected to 2 h of permanent middle cerebral artery occlusion (MCAO). Rats were administered either saline or a glutamate receptor antagonist; the non-competitive NMDA receptor antagonist MK-801 or the AMPA receptor antagonist NBQX which are known to be able to reduce infarct size in MCA occluded rats. The saline treated rats showed presence of Fos protein in nerve cell nuclei throughout the cortical and striatal infarct borderzone, but no staining in the infarct core or contralateral hemisphere. MK-801 almost totally abolished this expression of Fos protein whereas NBQX had no significant effect on Fos protein expression. It is suggested that the Fos protein induction is due to repeated spreading depressions mediated by NMDA receptors in the infarct borderzone, and that Fos protein due to its persistence in the tissue can be used as a histochemical marker of borderzone tissue at risk for eventually becoming recruited in the infarct.

AB - In the present immunocytochemical study, we investigated the mechanism of Fos protein induction and the regional distribution of the Fos protein in brains of spontaneously hypertensive rats subjected to 2 h of permanent middle cerebral artery occlusion (MCAO). Rats were administered either saline or a glutamate receptor antagonist; the non-competitive NMDA receptor antagonist MK-801 or the AMPA receptor antagonist NBQX which are known to be able to reduce infarct size in MCA occluded rats. The saline treated rats showed presence of Fos protein in nerve cell nuclei throughout the cortical and striatal infarct borderzone, but no staining in the infarct core or contralateral hemisphere. MK-801 almost totally abolished this expression of Fos protein whereas NBQX had no significant effect on Fos protein expression. It is suggested that the Fos protein induction is due to repeated spreading depressions mediated by NMDA receptors in the infarct borderzone, and that Fos protein due to its persistence in the tissue can be used as a histochemical marker of borderzone tissue at risk for eventually becoming recruited in the infarct.

KW - Animals

KW - Cerebral Cortex

KW - Cerebral Infarction

KW - Corpus Striatum

KW - Cortical Spreading Depression

KW - Dizocilpine Maleate

KW - Energy Metabolism

KW - Gene Expression Regulation

KW - Male

KW - Neurons

KW - Proto-Oncogene Proteins c-fos

KW - Quinoxalines

KW - Rats

KW - Rats, Inbred SHR

KW - Receptors, N-Methyl-D-Aspartate

M3 - Journal article

C2 - 8356885

VL - 87

SP - 510

EP - 515

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

SN - 0001-6314

IS - 6

ER -

ID: 272524